Spero Therapeutics Inc (SPRO)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $58.26M
Last updated: Nov 17, 2026 at 11:05 AM ET
Spero Therapeutics Inc (SPRO) Competitors
The companies most similar to Spero Therapeutics are Grace Therapeutics (GRCE), Mereo BioPharma Group PLC ADR (MREO) and Gain Therapeutics (GANX). By market cap, Spero Therapeutics ranks 5th of the 13 companies on this page; Pmv Pharmaceuticals (PMVP) is the largest at $95.93M.
Peer Comparison
SPRO's revenue growth of -95.6% is below the peer median of 0.0%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Spero Therapeutics (SPRO) | $58.26M | 11.1x | 1.3x | 15.7% | N/A | -95.6% | 0.00% |
| Grace Therapeutics, Inc. (GRCE) | $38.08M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Mereo BioPharma Group PLC ADR (MREO) | $49.11M | N/A | 61.3x | 0.0% | -116.6% | 0.0% | 0.00% |
| Gain Therapeutics Inc (GANX) | $46.31M | N/A | N/A | 0.0% | -170.5% | -100.0% | 0.00% |
| Serina Therapeutics Inc (SER) | $36.93M | N/A | 288.7x | 0.0% | -109.4% | 154.9% | 0.00% |
| Plus Therapeutics Inc (PSTV) | $26.64M | N/A | 2.0x | -230.2% | -827.8% | -2.9% | 0.00% |
| Heron Therapeuti (HRTX) | $59.08M | N/A | 0.4x | -14.5% | -8.4% | -7.8% | 0.00% |
| OS Therapies Incorporated (OSTX) | $34.87M | N/A | N/A | 0.0% | 218.0% | 0.0% | 0.00% |
| Neumora Therapeutics, Inc. (NMRA) | $80.59M | N/A | N/A | 0.0% | -260.5% | 0.0% | 0.00% |
| Pliant Therapeutics Inc (PLRX) | $43.21M | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| Pmv Pharmaceuticals Inc (PMVP) | $95.93M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Telomir Pharmaceuticals, Inc. Common Stock (TELO) | $36.15M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Verrica Pharmaceuticals Inc (VRCA) | $61.16M | N/A | 3.0x | -189.2% | -496.2% | -51.8% | 0.00% |
| Peer median | $44.76M | N/A | 3.0x | 0.0% | -143.5% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Spero Therapeutics, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Grace Therapeutics, Inc. (GRCE) | Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. | GRCE competitors |
| Mereo BioPharma Group PLC ADR (MREO) | Mereo BioPharma Group plc, a biopharmaceutical company, acquires, develops and markets therapeutic products for the treatment of oncology and rare diseases... | MREO competitors |
| Gain Therapeutics Inc (GANX) | Gain Therapeutics, Inc., a developing biotechnology company, is dedicated to developing a variety of therapies to treat diseases caused by protein misfolding. | GANX competitors |
| Serina Therapeutics Inc (SER) | Serina Therapeutics Inc is a pioneering biotechnology company focused on developing innovative solutions for unmet medical needs in oncology and neurology... | SER competitors |
| Plus Therapeutics Inc (PSTV) | Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacturing... | PSTV competitors |
| Heron Therapeuti (HRTX) | Heron Therapeutics, Inc., a biotechnology company, is dedicated to developing treatments to address unmet medical needs. | HRTX competitors |
| OS Therapies Incorporated (OSTX) | OS Therapies Incorporated is a pioneering biopharmaceutical company committed to developing innovative treatments for unmet medical needs... | OSTX competitors |
| Neumora Therapeutics, Inc. (NMRA) | Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases... | NMRA competitors |
| Pliant Therapeutics Inc (PLRX) | Pliant Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers, develops... | PLRX competitors |
| Pmv Pharmaceuticals Inc (PMVP) | PMV Pharmaceuticals, Inc., a precision oncology company, is dedicated to the discovery and development of small molecule tumor agnostic therapies for p53... | PMVP competitors |
| Telomir Pharmaceuticals, Inc. Common Stock (TELO) | Telomir Pharmaceuticals, Inc., a pre-clinical-stage pharmaceutical company, focuses on the development and commercialization of therapeutic treatment for human... | TELO competitors |
| Verrica Pharmaceuticals Inc (VRCA) | Verrica Pharmaceuticals Inc., a dermatological therapy company, develops and markets treatments for people with skin conditions in the United States. | VRCA competitors |
Frequently Asked Questions About SPRO
Who are Spero Therapeutics' main competitors?
The companies most similar to Spero Therapeutics include Grace Therapeutics (GRCE), Mereo BioPharma Group PLC ADR (MREO), Gain Therapeutics (GANX), Serina Therapeutics (SER) and Plus Therapeutics (PSTV), listed from the closest match.
Who is Spero Therapeutics' biggest competitor?
Pmv Pharmaceuticals (PMVP) is the largest of the similar companies at $95.93M; Grace Therapeutics (GRCE) is the closest match by business profile, size, sector and industry.
How does SPRO stock compare with its competitors?
SPRO's P/S is 1.3x against a peer median of 3.0x; its net margin is 15.7% against a peer median of 0.0%.
Which of Spero Therapeutics' competitors pays a higher dividend?
Spero Therapeutics pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Spero Therapeutics bigger than its competitors?
No. Spero Therapeutics is 5th by market cap among the 13 companies on this page; the largest is Pmv Pharmaceuticals (PMVP) at $95.93M.
SPRO pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts